turabe m h u fazil
Nanyang Technological University
Singapore, Singapore
Review Editor
Cancer Immunity and Immunotherapy
Nanyang Technological University
Singapore, Singapore
Review Editor
Cancer Immunity and Immunotherapy
Federal University of Health Sciences of Porto Alegre
Porto Alegre, Brazil
Review Editor
Cancer Immunity and Immunotherapy
Oslo University Hospital
Oslo, Norway
Review Editor
Cancer Immunity and Immunotherapy
Hackensack University Medical Center
Hackensack, United States
Review Editor
Cancer Immunity and Immunotherapy
Center for Discovery and Innovation, Hackensack Meridian Health
Nutley, United States
Review Editor
Cancer Immunity and Immunotherapy
University College London
London, United Kingdom
Review Editor
Cancer Immunity and Immunotherapy
Qinghai University Medical College
Xining, China
Review Editor
Cancer Immunity and Immunotherapy
School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney
Sydney, Australia
Review Editor
Cancer Immunity and Immunotherapy
Yale University
New Haven, United States
Review Editor
Cancer Immunity and Immunotherapy
CCT CONICET CĂłrdoba
Cordoba, Argentina
Review Editor
Cancer Immunity and Immunotherapy
National Cancer Institute Foundation (IRCCS)
Milan, Italy
Review Editor
Cancer Immunity and Immunotherapy
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Cancer Immunity and Immunotherapy
Josep Carreras Leukaemia Research Institute (IJC)
Badalona, Spain
Review Editor
Cancer Immunity and Immunotherapy
Massachusetts General Hospital, Harvard Medical School
Boston, United States
Review Editor
Cancer Immunity and Immunotherapy
SOTIO a.s.
Prague, Czechia
Review Editor
Cancer Immunity and Immunotherapy
School of Medicine, Washington University in St. Louis
St. Louis, United States
Review Editor
Cancer Immunity and Immunotherapy